Journal article Open access Published 2023
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines
Investigational New Drugs 41(2), 210-219 (2023)
- 2023 Year
- 36913160 PMID
Cite this publication
DOSTÁLOVÁ, H., R. JORDA, E. ŘEZNÍČKOVÁ, V. KRYŠTOF: Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160, PDF.
Details
- ISSN
- 0167-6997